Media headlines about LHC Group (NASDAQ:LHCG) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. LHC Group earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned media stories about the health services provider an impact score of 46.726721692692 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

Shares of LHC Group (LHCG) traded up 0.25% on Monday, reaching $67.83. The company’s stock had a trading volume of 91,573 shares. The stock has a market cap of $1.24 billion, a PE ratio of 30.01 and a beta of 0.76. LHC Group has a 12-month low of $32.04 and a 12-month high of $73.85. The firm has a 50 day moving average price of $66.89 and a 200-day moving average price of $62.65.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million for the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company’s quarterly revenue was up 15.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.52 EPS. Equities research analysts expect that LHC Group will post $2.39 EPS for the current year.

Several equities research analysts recently commented on the company. Royal Bank Of Canada reaffirmed a “buy” rating and set a $70.00 price objective on shares of LHC Group in a research report on Wednesday, September 6th. BidaskClub raised LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Zacks Investment Research raised LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective on the stock in a research report on Saturday, August 5th. Jefferies Group LLC reaffirmed a “buy” rating and set a $68.00 price objective on shares of LHC Group in a research report on Friday, August 4th. Finally, Robert W. Baird reaffirmed a “hold” rating and set a $63.00 price objective on shares of LHC Group in a research report on Tuesday, September 12th. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $66.60.

ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect LHC Group (LHCG) Stock Price” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.watchlistnews.com/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-lhc-group-lhcg-stock-price/1650152.html.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the sale, the chief operating officer now owns 109,235 shares in the company, valued at approximately $7,137,414.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.80% of the stock is currently owned by insiders.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with Analyst Ratings Network's FREE daily email newsletter.